MedTrace Logo

Selegiline in Treatment of Cocaine Dependence - 2

NCT00000188 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-05-28

No results posted yet for this study

Summary

The purpose of this study is to assess selegiline as a pharmacotherapy for cocaine dependence.

Conditions

  • Cocaine-Related Disorders

Interventions

DRUG

Selegiline

Sponsors & Collaborators

Principal Investigators

  • James Cornish, M.D. · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1994-09-30
Primary Completion
1995-10-31
Completion
1995-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000188 on ClinicalTrials.gov